Feb 27 (Reuters) - Star Combo Pharma Ltd (S66) :
- HY OPERATING LOSS ATTRIBUTABLE A$4.4 MILLION VERSUS LOSS A$997
- HY REVENUE A$11.6 MILLION VERSUS A$11.8 MILLION
- BUSINESS STRATEGY IN FY23 REMAINS FOCUSED ON GROWING ITS CONTRACT MANUFACTURING OPERATIONS
- Forums
- ASX - By Stock
- S66
- News: S66 Star Combo Pharma Says HY Operating Loss Attributable A$4.4 Million
News: S66 Star Combo Pharma Says HY Operating Loss Attributable A$4.4 Million
Featured News
Add S66 (ASX) to my watchlist
(20min delay)
|
|||||
Last
11.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.85M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 11.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.0¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.110 |
1 | 96390 | 0.105 |
1 | 6000 | 0.100 |
1 | 31578 | 0.095 |
1 | 25000 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.140 | 100000 | 1 |
0.150 | 18242 | 2 |
0.170 | 86002 | 1 |
0.185 | 29724 | 2 |
0.190 | 172005 | 1 |
Last trade - 16.12pm 22/07/2024 (20 minute delay) ? |
Featured News
S66 (ASX) Chart |
Day chart unavailable